4.6 Article

Novel albumin-binding photodynamic agent EB-Ppa for targeted fluorescent imaging guided tumour photodynamic therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin Coated AIE Aggregates

Keke Ding et al.

Summary: This study developed a photoenhanced cancer chemotherapy strategy using near-infrared fluorescence imaging, photodynamic therapy, and photothermal therapy to enhance the sensitivity of bladder cancer to cisplatin chemotherapy with minimal side effects.

ACS NANO (2022)

Article Nanoscience & Nanotechnology

Molecular and Supramolecular Approach to Highly Photocytotoxic Phthalocyanines with Dual Cell Uptake Pathways and Albumin-Enhanced Tumor Targeting

Hao Liu et al.

Summary: This paper presents a molecular and supramolecular approach for targeted phototherapy by modifying silicon (IV) phthalocyanines (Pcs) and interacting with albumin. The approach improves the photoactivities and tumor targeting of Pcs, and achieves high phototoxicity in HepG2 cells.

ACS APPLIED MATERIALS & INTERFACES (2022)

Article Engineering, Biomedical

In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer

Xingshu Li et al.

Summary: The study demonstrates a clinically promising approach that combines a water-soluble phthalocyanine derivative and a hypoxia-activated prodrug to enhance the efficacy of PDT and improve cancer immunotherapy. This dual delivery method overcomes limitations of hypoxia in PDT and significantly activates CD8(+) T cells, showing potential for enhanced therapeutic outcomes in cancer treatment.

BIOMATERIALS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Chemistry, Multidisciplinary

Hows and Whys of Tumor-Seeking Dyes

Syed Muhammad Usama et al.

Summary: The text discusses the application and advantages of active targeting in the medical field, as well as the important role of tumor-seeking dyes in overcoming tumor heterogeneity.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

Review Nanoscience & Nanotechnology

Cancer nanotechnology: current status and perspectives

Jessica A. Kemp et al.

Summary: Modern medicine has been fighting against cancer for nearly a century with no clear end in sight. The need to increase specificity and decrease systemic toxicities in cancer treatments remains. Nanotechnology shows potential in revolutionizing diagnostic tools and improving patient care in cancer treatment.

NANO CONVERGENCE (2021)

Article Oncology

The ever-increasing importance of cancer as a leading cause of premature death worldwide

Freddie Bray et al.

Summary: CVD and cancer are now leading causes of premature death in 127 countries with cancer poised to overtake CVD in most countries over the course of this century. Governments must consider these transitions in disease profiles when developing cancer policies at the local level.

CANCER (2021)

Review Chemistry, Multidisciplinary

Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies

Jianlei Xie et al.

Summary: Photodynamic therapy (PDT) has shown great potential in tumor treatment due to its non-invasiveness, spatiotemporal selectivity, lower side-effects, and immune activation ability. However, the clinical application of PDT is restricted by various factors such as traditional photosensitizer limitations, light penetration issues, tumor resistance, and pain induction. Recent advancements in using nanomaterials as photosensitizers or carriers, combined with optimized therapy strategies, have shown promising results in overcoming these barriers and improving the effectiveness of PDT in cancer treatment.

CHEMICAL SOCIETY REVIEWS (2021)

Review Medicine, Research & Experimental

Recent advances in innovative strategies for enhanced cancer photodynamic therapy

Tingting Hu et al.

Summary: Photodynamic therapy (PDT) is a non-invasive therapeutic modality that has gained attention for its high selectivity and limited side effects. However, limitations such as inadequate light penetration depth and non-targeting photosensitizers have hindered its full clinical application. Current research focuses on innovative strategies to overcome these limitations and enhance the therapeutic effect of PDT.

THERANOSTICS (2021)

Article Chemistry, Medicinal

Synthesis and evaluation of novel chlorophyll a derivatives as potent photosensitizers for photodynamic therapy

Ying-Hua Gao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Engineering, Biomedical

Advances in nanomaterials for photodynamic therapy applications: Status and challenges

Jianming Chen et al.

BIOMATERIALS (2020)

Review Chemistry, Multidisciplinary

Emerging combination strategies with phototherapy in cancer nanomedicine

Zhongjian Xie et al.

CHEMICAL SOCIETY REVIEWS (2020)

Article Medicine, Research & Experimental

cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy

Wenjing Li et al.

MOLECULAR PHARMACEUTICS (2018)

Article Biochemical Research Methods

On the Mechanisms of Uptake of Tumor-Seeking Cyanine Dyes

Syed Muhammad Usama et al.

BIOCONJUGATE CHEMISTRY (2018)

Article Gastroenterology & Hepatology

SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer

Juan Vaz et al.

PANCREAS (2015)

Review Chemistry, Multidisciplinary

Functional Nanomaterials for Phototherapies of Cancer

Liang Cheng et al.

CHEMICAL REVIEWS (2014)

Article Multidisciplinary Sciences

Optimization of Evans blue quantitation in limited rat tissue samples

Hwai-Lee Wang et al.

SCIENTIFIC REPORTS (2014)

Article Gastroenterology & Hepatology

Advance in Photosensitizers and Light Delivery for Photodynamic Therapy

Il Yoon et al.

CLINICAL ENDOSCOPY (2013)

Review Biochemistry & Molecular Biology

Like a Bolt from the Blue: Phthalocyanines in Biomedical Optics

Nawal Sekkat et al.

MOLECULES (2012)

Review Pharmacology & Pharmacy

Prodrugs for improving tumor targetability and efficiency

Rubi Mahato et al.

ADVANCED DRUG DELIVERY REVIEWS (2011)

Article Biochemistry & Molecular Biology

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

Makoto Mitsunaga et al.

NATURE MEDICINE (2011)

Review Biochemistry & Molecular Biology

Targeted photodynamic therapy - a promising strategy of tumor treatment

Andrzej M. Bugaj

PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)

Article Pharmacology & Pharmacy

Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties

Matthias Wacker et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)

Article Biochemical Research Methods

Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent

Klara Stefflova et al.

BIOCONJUGATE CHEMISTRY (2007)

Review Pharmacology & Pharmacy

Targeted photodynamic therapy via receptor mediated delivery systems

WM Sharman et al.

ADVANCED DRUG DELIVERY REVIEWS (2004)

Article Biochemical Research Methods

Pyropheophorbide 2-deoxyglucosamide: A new photosensitizer targeting glucose transporters

M Zhang et al.

BIOCONJUGATE CHEMISTRY (2003)

Article Pharmacology & Pharmacy

Desolvation process and surface characteristics of HSA-nanoparticles

C Weber et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)